These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 30798282)

  • 41. Diagnostic and prognostic role of procalcitonin (PCT) and MR-pro-Adrenomedullin (MR-proADM) in bacterial infections.
    Angeletti S; Spoto S; Fogolari M; Cortigiani M; Fioravanti M; De Florio L; Curcio B; Cavalieri D; Costantino S; Dicuonzo G
    APMIS; 2015 Sep; 123(9):740-8. PubMed ID: 26058482
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term prognostic value of mid-regional pro-adrenomedullin and C-terminal pro-endothelin-1 in patients with acute myocardial infarction.
    Behnes M; Papassotiriou J; Walter T; Fiedler E; Sauer T; Lang S; Elmas E; Hoffmann U; Borggrefe M; Brueckmann M
    Clin Chem Lab Med; 2008; 46(2):204-11. PubMed ID: 18076360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relation between Mid-Regional Pro-Adrenomedullin in Patients with Chronic Heart Failure and the Dose of Diuretics in 2-Year Follow-Up-Data from FAR NHL Registry.
    Špinarová M; Špinar J; Špinarová L; Krejčí J; Goldbergová-Pávková M; Pařenica J; Ludka O; Málek F; Ošťádal P; Benešová K; Jarkovský J; Lábr K
    Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295637
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of long-term prognostic value of N-terminal-proBNP and midregional-pro-adrenomedullin in patients with acute myocardial infarction.
    Walter T; Brueckmann M; Lang S; Sauer T; Fiedler E; Papassotiriou J; Behnes M; Elmas E; Borggrefe M; Bertsch T
    Clin Lab; 2010; 56(7-8):303-9. PubMed ID: 20857894
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mid-regional pro-adrenomedullin as a predictor of in-hospital mortality in adult patients with COVID-19: a single-centre prospective study.
    Popov D; Borovkova U; Rybka M; Ramnyonok T; Golukhova E
    Anaesthesiol Intensive Ther; 2022; 54(3):242-246. PubMed ID: 36062419
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mid-Regional Pro-Adrenomedullin in Combination With Pediatric Early Warning Scores for Risk Stratification of Febrile Children Presenting to the Emergency Department: Secondary Analysis of a Nonprespecified United Kingdom Cohort Study.
    Lenihan RAF; Ang J; Pallmann P; Romaine ST; Waldron CA; Thomas-Jones E; Miah N; Carrol ED
    Pediatr Crit Care Med; 2022 Dec; 23(12):980-989. PubMed ID: 36239515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of COVID-19 patients at risk of hospital admission and mortality: a European multicentre retrospective analysis of mid-regional pro-adrenomedullin.
    Sozio E; Moore NA; Fabris M; Ripoli A; Rumbolo F; Minieri M; Boverio R; Rodríguez Mulero MD; Lainez-Martinez S; Martínez Martínez M; Calvo D; Gregoriano C; Williams R; Brazzi L; Terrinoni A; Callegari T; Hernández Olivo M; Esteban-Torrella P; Calcerrada I; Bernasconi L; Kidd SP; Sbrana F; Miguens I; Gordon K; Visentini D; Legramante JM; Bassi F; Cortes N; Montrucchio G; Di Lecce VN; Lauritano EC; García de Guadiana-Romualdo L; González Del Castillo J; Bernal-Morell E; Andaluz-Ojeda D; Schuetz P; Curcio F; Tascini C; Saeed K
    Respir Res; 2022 Aug; 23(1):221. PubMed ID: 36031619
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
    Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
    J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mid-regional pro-adrenomedullin and ST2 in heart failure: Contributions to diagnosis and prognosis.
    Lopes D; Menezes Falcão L
    Rev Port Cardiol; 2017 Jun; 36(6):465-472. PubMed ID: 28606358
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adrenomedullin optimises mortality prediction in COPD patients.
    Brusse-Keizer M; Zuur-Telgen M; van der Palen J; VanderValk P; Kerstjens H; Boersma W; Blasi F; Kostikas K; Milenkovic B; Tamm M; Stolz D
    Respir Med; 2015 Jun; 109(6):734-42. PubMed ID: 25937049
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The influence of diabetes mellitus on midregional proadrenomedullin concentrations and prognostic value in heart failure outpatients.
    Holmager P; Schou M; Egstrup M; Gustafsson I; Goetze JP; Gustafsson F; Klausen TW; Faber J; Kistorp C
    J Card Fail; 2015 Mar; 21(3):250-7. PubMed ID: 25528198
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systematic review with meta-analysis of mid-regional pro-adrenomedullin (MR-proadm) as a prognostic marker in Covid-19-hospitalized patients.
    Fialek B; De Roquetaillade C; Pruc M; Navolokina A; Chirico F; Ladny JR; Peacock FW; Szarpak L
    Ann Med; 2023 Dec; 55(1):379-387. PubMed ID: 36607317
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MR-proANP and MR-proADM for risk stratification of patients with acute chest pain.
    Tzikas S; Keller T; Ojeda FM; Zeller T; Wild PS; Lubos E; Kunde J; Baldus S; Bickel C; Lackner KJ; Münzel TF; Blankenberg S
    Heart; 2013 Mar; 99(6):388-95. PubMed ID: 23213173
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The prognostic value of mid-regional pro-adrenomedullin in the evaluation of acute dyspnea.
    Choi JJ; McCarthy MW
    Expert Rev Mol Diagn; 2018 Feb; 18(2):147-153. PubMed ID: 29319365
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mr-Proadm Elevation Upon Icu Admission Predicts the Outcome of Septic Patients and is Correlated with Upcoming Fluid Overload.
    Charles PE; Péju E; Dantec A; Bruyère R; Meunier-Beillard N; Dargent A; Prin S; Wilson D; Quenot JP
    Shock; 2017 Oct; 48(4):418-426. PubMed ID: 28414691
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MR-proADM as prognostic factor of outcome in COVID-19 patients.
    Sozio E; Tascini C; Fabris M; D'Aurizio F; De Carlo C; Graziano E; Bassi F; Sbrana F; Ripoli A; Pagotto A; Giacinta A; Gerussi V; Visentini D; De Stefanis P; Merelli M; Saeed K; Curcio F
    Sci Rep; 2021 Mar; 11(1):5121. PubMed ID: 33664308
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How biomarkers can improve pneumonia diagnosis and prognosis: procalcitonin and mid-regional-pro-adrenomedullin.
    Spoto S; Legramante JM; Minieri M; Fogolari M; Terrinoni A; Valeriani E; Sebastiano C; Bernardini S; Ciccozzi M; Angeletti PS
    Biomark Med; 2020 May; 14(7):549-562. PubMed ID: 32462910
    [No Abstract]   [Full Text] [Related]  

  • 58. Mid-regional pro-adrenomedullin as a supplementary tool to clinical parameters in cases of suspicion of infection in the emergency department.
    Saeed K; Legramante JM; Angeletti S; Curcio F; Miguens I; Poole S; Tascini C; Sozio E; Del Castillo JG
    Expert Rev Mol Diagn; 2021 Apr; 21(4):397-404. PubMed ID: 33736553
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Associations of mid-regional pro-adrenomedullin levels to cardiovascular and metabolic abnormalities, and mortality in an elderly population from the community.
    Eggers KM; Venge P; Lindahl B; Lind L
    Int J Cardiol; 2013 Oct; 168(4):3537-42. PubMed ID: 23722054
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biomarker guided triage can reduce hospitalization rate in community acquired febrile urinary tract infection.
    Stalenhoef JE; van Nieuwkoop C; Wilson DC; van der Starre WE; Delfos NM; Leyten EMS; Koster T; Ablij HC; Van't Wout JJW; van Dissel JT
    J Infect; 2018 Jul; 77(1):18-24. PubMed ID: 29807091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.